Cargando…
NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer
BACKGROUND: Triple Negative breast cancer (TNBC) is a poor outcome subgroup of breast cancer defined based on the absence of expression of ERα and PR and HER2 amplification. These hard to treat cancers lack targeted treatment options and are therefore treated with a standard of care (SoC) generic co...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444590/ https://www.ncbi.nlm.nih.gov/pubmed/30935371 http://dx.doi.org/10.1186/s12885-019-5407-9 |